Structural Biology and Molecular Modelling Market - PowerPoint PPT Presentation

View by Category
About This Presentation

Structural Biology and Molecular Modelling Market


The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. – PowerPoint PPT presentation

Number of Views:1
Date added: 2 January 2020
Slides: 8
Provided by: devinsmith


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Structural Biology and Molecular Modelling Market

Structural Biology and Molecular Modeling Market
To Reach USD 14.97 Billion By 2026
Market Summary
Structural Biology and Molecular Modeling
Market The rising presence of contract research
organizations, increasing healthcare IT spending,
and unprecedented evolution of the healthcare
infrastructure and standards, rise in the
prevalence of chronic diseases are key factors
contributing to high CAGR of structural biology
and molecular modeling during the forecast
period. Market Size USD 4 Billion in 2018,
Market Growth - CAGR of 17.9, Market Trends
Product launches and research for advanced
Structural biology and molecular modeling
Our Approach
Market Summary
  • According to the current analysis of Reports and
    Data, the global structural biology and molecular
    modeling market was valued at USD 4.00 billion in
    2018 and is expected to reach USD 14.97 billion
    by the year 2026, at a CAGR of 17.9. The global
    structural biology and molecular modeling market
    is an essential part of the worldwide healthcare
    sector and has already made vital contributions
    in obtaining remedies to several diseases.
  • Improving the quality of medicine and healthcare,
    in general, has been a key focus of governments
    across the world in recent years due to the
    rising volume of patient demographics and the
    growing geriatric population. This has driven
    consistent investment in medical research in
    recent years, making steady development of the
    structural biology and molecular modeling
    techniques market likely in the future
  • Request for a sample of this research report _at_

Our Approach
Market Summary
  • Further key findings from the report suggest
  • Researchers of the University of Natural
    Resources and Life Sciences in Austria proceed
    out molecular dynamics simulations to study the
    activity of humanized antibodies (Ab2/3H6), which
    is believed to neutralize HIV-1.
  • Large drug attrition rate associated with
    late-phase clinical trials in drug development is
    a significant contributor of the elevated costs,
    which is further presumed to propel the demand
    for modeling techniques to reduce the probability
    of drug failure.
  • Potency determination of a new drug molecule in
    the silicon screening of 3-D chemical structures
    expedite the lead discovery and optimization
    process, thereby allowing the greater focus to be
    laid on targets with high therapeutic potential.
  • North America captured a dominant share in the
    overall structural biology molecular modeling
    techniques market with 35. Heightening their RD
    capabilities to ensure high medical standards is
    expected to propel the demand in this region.
  • To identify the key trends in the industry, click
    on the link below https//

Our Approach
Market Summary
  • The key players are AlDassault Systemes, Agile
    Molecule, Accellera Ltd., Bioinformatic LLC,
    Affymetrix, Agilent Technologies, Inc., Illumina,
    Bruker Daltonics Inc., Biomax Informatics AG,
    Chemical Computing Group, and CLC bio
  • For the purpose of this report, Reports and Data
    has segmented the market on the basis of source,
    product, application, and region
  • Product (Revenue, USD Million 20162026)
  • SaaS standalone modeling
  • Homology modeling
  • Threading
  • Molecular dynamics
  • Ab Initio
  • Hybrid
  • Others
  • Visualization analysis
  • Databases
  • Others

Our Approach
  • Application (Revenue, USD Million 20162026)
  • Drug development
  • Drug discovery
  • Others
  • Regional Outlook (Revenue in USD Million
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of the Europe
  • Order Now https//

About Us
Our Approach
About Us
  • Reports and Data is a market research and
    consulting company that provides syndicated
    research reports, customized research reports,
    and consulting services. Our solutions purely
    focus on your purpose to locate, target and
    analyze consumer behavior shifts across
    demographics, across industries and help clients
    make a smarter business decision. We offer market
    intelligence studies ensuring relevant and
    fact-based research across a multiple industries
    including Healthcare, Technology, Chemicals,
    Power, and Energy. We consistently update our
    research offerings to ensure our clients are
    aware about the latest trends existent in the
    market. Reports and Data has a strong base of
    experienced analysts from varied areas of
  • Contact Us
  • John Watson
  • Head of Business Development
  • Reports And Data Web
  • Direct Line 1-212-710-1370
  • E-mail